Johnson & Johnson (NYSE: JNJ) and Crucell N.V. (NASDAQ: CRXL) announced that Johnson & Johnson, through its subsidiary Ortho-McNeil-Janssen Pharmaceuticals ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE